Trials
Home > Clinical Trials
– Our Research –
Clinical Trials
Human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) are retroviruses found worldwide. Of the 2 viruses, HTLV-1 has been more often associated with human disease. Please see below a list of HTLV guidelines and clinical trials.
Planned Trial: Anti-chemokine receptor 4 Chimeric Antigen Receptor cells
Planned trial: Phase I trial of anti-chemokine receptor 4 Chimeric Antigen Receptor cells (CCR4-CARs) for the...
Ongoing Trial: Human Immune Response
Ongoing clinical trials at NCI that are exclusive to or include patients with ATL: Investigation of the Human Immune...
Ongoing Trial: Subcutaneous Recombinant rhIL-15 & Alemtuzumab
Ongoing clinical trials at NCI that are exclusive to or include patients with ATL: Subcutaneous Recombinant Human...
Planned Trial: rhIL-15 & Mogamulizumab
Planned trial: Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult...